These data include the findings that ACPAs are present in the sputum of a subset of at-risk individuals in the absence of serum ACPA positivity and that ACPAs are highly prevalent in the sputum and bronchoalveolar lavage fluid of established RA patients [13, 14, 20]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.